| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P50 | author | Carlo Maria Croce | Q640381 |
| Thomas D. Schmittgen | Q56867888 | ||
| Stefano Volinia | Q28324641 | ||
| P2093 | author name string | Bo Wang | |
| Huban Kutay | |||
| Kalpana Ghoshal | |||
| Samson T Jacob | |||
| Gerard J Nuovo | |||
| Sarmila Majumder | |||
| Chang-Gong Liu | |||
| Jharna Datta | |||
| Mohd W Nasser | |||
| P2860 | cites work | EUKARYOTIC CYTOSINE METHYLTRANSFERASES | Q22255656 |
| Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer | Q24564615 | ||
| DNA methylation and gene silencing in cancer | Q36338042 | ||
| Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression | Q36459023 | ||
| Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription | Q36459959 | ||
| Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade | Q36512697 | ||
| The Met pathway: master switch and drug target in cancer progression | Q36549360 | ||
| c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy | Q36731520 | ||
| Mechanisms of microRNA-mediated gene regulation in animal cells | Q36763232 | ||
| DNA methyltransferases as targets for cancer therapy | Q36870920 | ||
| FOXP1: a potential therapeutic target in cancer. | Q36871999 | ||
| Unraveling the epigenetic code of cancer for therapy | Q36903205 | ||
| Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure | Q39675513 | ||
| The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. | Q40169748 | ||
| Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation | Q42481666 | ||
| Analysis of promoter methylation and its role in silencing metallothionein I gene expression in tumor cells | Q44037788 | ||
| Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. | Q44343231 | ||
| Met-thodology | Q79715135 | ||
| Downregulation of miR-122 in the rodent and human hepatocellular carcinomas | Q24631076 | ||
| The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding | Q24644692 | ||
| The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
| Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications | Q24683729 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 | ||
| DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
| HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention | Q28240437 | ||
| Histone deacetylases and cancer | Q28240447 | ||
| Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 | ||
| Human FOX gene family (Review) | Q28288603 | ||
| Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 | ||
| Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal | Q28384242 | ||
| A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats | Q28566367 | ||
| Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma | Q28572444 | ||
| Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells | Q28580458 | ||
| DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2 | Q28584099 | ||
| MicroRNA biogenesis: coordinated cropping and dicing | Q29547496 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| Phenotypic plasticity and the epigenetics of human disease | Q29614515 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas | Q33193334 | ||
| Regulation of metallothionein gene expression | Q34070583 | ||
| Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin | Q34188997 | ||
| Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype | Q34619635 | ||
| Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin | Q35788665 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| gene silencing | Q1431332 | ||
| carcinogenesis | Q1637543 | ||
| P304 | page(s) | 5049-58 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis | |
| P478 | volume | 68 |
| Q39022413 | 4-(Methylnitrosamino)-1-(3-pyridyl) -1-butanone induces circulating microRNA deregulation in early lung carcinogenesis. |
| Q38796678 | A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression |
| Q47743546 | A Methyl-Balanced Diet Prevents CRF-Induced Prenatal Stress-Triggered Predisposition to Binge Eating-like Phenotype. |
| Q38605223 | A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer. |
| Q38962643 | A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer |
| Q33901844 | A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation |
| Q27349177 | A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia |
| Q26740327 | A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer |
| Q47266960 | A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk |
| Q39996382 | A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas |
| Q34216030 | A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus |
| Q38795700 | A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma |
| Q41471073 | ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis. |
| Q34149629 | Aberrant epigenetic landscape in cancer: how cellular identity goes awry |
| Q34916406 | Aberrant epigenetic reprogramming of imprinted microRNA-127 and Rtl1 in cloned mouse embryos. |
| Q47191085 | Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma. |
| Q37295063 | Advances in microRNAs: implications for immunity and inflammatory diseases |
| Q45925779 | Alterations of epigenetics and microRNA in hepatocellular carcinoma. |
| Q35136675 | Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach |
| Q38769905 | An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma |
| Q36618996 | An emerging role for microRNA in the regulation of endothelin-1. |
| Q33533878 | An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. |
| Q112288695 | An integrated analysis of DNA promoter methylation, microRNA regulation, and gene expression in gastric adenocarcinoma |
| Q34166724 | Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer |
| Q35605072 | Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. |
| Q38859326 | Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma. |
| Q46888708 | Biochemical and molecular evidences for the antitumor potential of Ginkgo biloba leaves extract in rodents |
| Q38761133 | Bone microRNAs and aging |
| Q38047676 | Cancer genetics and genomics of human FOX family genes |
| Q24594739 | Cancer microRNAs: from subtype profiling to predictors of response to therapy |
| Q38066032 | Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q36316601 | Cell-free Circulating miRNA Biomarkers in Cancer |
| Q38046107 | Cellular and molecular mechanisms of hepatocellular carcinoma: an update |
| Q85174013 | Cellular context in epigenetics: quantitative multicolor imaging and automated per-cell analysis of miRNAs and their putative targets |
| Q90672469 | Circulating MiR-10b, MiR-1 and MiR-30a Expression Profiles in Lung Cancer: Possible Correlation with Clinico-pathologic Characteristics and Lung Cancer Detection |
| Q26746000 | Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers |
| Q37406199 | Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma |
| Q38758317 | Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers |
| Q37568629 | Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. |
| Q42316244 | Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma |
| Q39201820 | Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. |
| Q46123967 | Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinoma |
| Q58558612 | Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma |
| Q39297036 | Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis |
| Q33627871 | Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate. |
| Q33801752 | Cross-talk between miRNA and Notch signaling pathways in tumor development and progression |
| Q37611820 | DNA methylation and cancer diagnosis: new methods and applications |
| Q26998741 | DNA methylation and microRNA dysregulation in cancer |
| Q38681154 | DNA methylation at enhancer regions: Novel avenues for epigenetic biomarker development. |
| Q34133706 | DNA methylation of cancer genome. |
| Q37962577 | DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family |
| Q35197356 | DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. |
| Q37921080 | DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer |
| Q92908814 | Demethylation of miR-195 suppresses prostate cancer cell proliferation, migration and invasion |
| Q54570256 | Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. |
| Q38163815 | Deregulation of microRNA expression in thyroid neoplasias |
| Q92684016 | Detection of DNA methylated microRNAs in hepatocellular carcinoma |
| Q38719441 | Development of MicroRNA Therapeutics for Hepatocellular Carcinoma |
| Q39505285 | Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer |
| Q36812809 | Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice |
| Q33273626 | Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression |
| Q41241323 | Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus |
| Q33854463 | Distinct microRNA alterations characterize high- and low-grade bladder cancer |
| Q39021212 | Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma |
| Q41905375 | Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation and is Associated with Prognosis of Skin Cancer by Targeting TGIF2. |
| Q39688414 | Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. |
| Q54431730 | Down-regulation of Dicer in hepatocellular carcinoma. |
| Q24655144 | Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 |
| Q37286505 | Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest |
| Q41135874 | Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma |
| Q53574351 | Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas. |
| Q97073512 | Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes |
| Q38828506 | Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer |
| Q38927654 | Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. |
| Q38771636 | Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. |
| Q91084691 | Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells |
| Q38613525 | Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review |
| Q58680923 | EU research activities in alternative testing strategies: current status and future perspectives |
| Q35787278 | EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma |
| Q42219159 | Ectopic expression of micro-RNA-1, 21 and 125a in peripheral blood immune cells is associated with chronic HBV infection |
| Q35625384 | Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells |
| Q38889577 | Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective. |
| Q39065092 | Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell |
| Q37973293 | Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer |
| Q27490492 | Emerging role of microRNAs in liver diseases |
| Q35419043 | Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer. |
| Q37689939 | Emerging role of small ribonucleic acids in gastrointestinal tumors |
| Q37844619 | Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q38660013 | Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies |
| Q39433158 | Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy |
| Q37830385 | Epigenetic aberrations during oncogenesis. |
| Q36294643 | Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. |
| Q37961805 | Epigenetic architecture and miRNA: reciprocal regulators. |
| Q38054874 | Epigenetic deregulation of microRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma |
| Q37336864 | Epigenetic marks in melanoma. |
| Q53131798 | Epigenetic regulation of DNMT1 gene in mouse model of asthma disease. |
| Q39310726 | Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3. |
| Q37965026 | Epigenetic regulation of miRNA genes in acute leukemia. |
| Q38041523 | Epigenetic regulation of miRNAs in cancer |
| Q37855202 | Epigenetic regulation of microRNAs in cancer: an integrated review of literature |
| Q45352825 | Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma |
| Q39514896 | Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer |
| Q38303814 | Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo |
| Q33572313 | Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer |
| Q39852549 | Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia |
| Q33711986 | Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome |
| Q57461616 | Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers |
| Q36860286 | Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype |
| Q51770872 | Epigenetics and MicroRNAs in Cancer. |
| Q37797691 | Epigenetics and miRNAs in human cancer |
| Q59538674 | Epigenetics, MicroRNAs, and Cancer: An Update |
| Q37583650 | Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation |
| Q34148217 | Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. |
| Q45388785 | Epstein-Barr virus-mediated dysregulation of human microRNA expression |
| Q39627532 | Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics |
| Q104496280 | Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format |
| Q37592190 | Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. |
| Q34611561 | FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma |
| Q37993339 | Feedback networks between microRNAs and epigenetic modifications in urological tumors. |
| Q33742006 | Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver |
| Q28383729 | From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms |
| Q38019039 | Functional genomic studies: insights into the pathogenesis of liver cancer. |
| Q28293339 | Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer |
| Q37241550 | Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a |
| Q27488345 | Gene expression and hepatitis C virus infection |
| Q38664137 | Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases |
| Q36402751 | Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma |
| Q26863460 | Genome-wide epigenetic regulation of miRNAs in cancer |
| Q34198100 | Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. |
| Q36296735 | HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis. |
| Q33818402 | HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors |
| Q37334563 | Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway |
| Q59355524 | Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers |
| Q38646734 | HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma |
| Q28534598 | High-throughput miRNA and mRNA sequencing of paired colorectal normal, tumor and metastasis tissues and bioinformatic modeling of miRNA-1 therapeutic applications |
| Q26783620 | Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis |
| Q57781169 | Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective |
| Q34298745 | Histone deacetylases and cancer. |
| Q34932080 | How epigenetics can explain human metastasis: a new role for microRNAs |
| Q33747273 | Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). |
| Q38721792 | Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3. |
| Q38585070 | Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma |
| Q38728864 | Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells |
| Q34577943 | Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancers. |
| Q28388119 | Identification of genomic features in environmentally induced epigenetic transgenerational inherited sperm epimutations |
| Q40017969 | Identification of microRNAs caused by DNA methylation that induce metastasis |
| Q48162391 | Identification of novel candidate regulators of retinotectal map formation through transcriptional profiling of the chick optic tectum. |
| Q38572855 | Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review |
| Q37781132 | In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets |
| Q83381651 | Increased expression of miR-34a in mouse spleen one day after exposure to N-ethyl-N-nitrosourea |
| Q37045770 | Increased gene expression of FOXP1 in patients with autism spectrum disorders |
| Q38847945 | Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review). |
| Q26770381 | Interplay Between Metabolism and Oncogenic Process: Role of microRNAs |
| Q37759740 | Interplay between microRNAs and the epigenetic machinery: an intricate network |
| Q34646522 | Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation |
| Q33566639 | KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells |
| Q35573029 | Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis |
| Q47691629 | Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis |
| Q92002429 | MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells |
| Q38747135 | Metal-dependent Deacetylases: Cancer and Epigenetic Regulators |
| Q39278094 | Methylation mediated silencing of miR-23b expression and its role in glioma stem cells |
| Q53239737 | Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. |
| Q42275337 | Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC. |
| Q64228693 | MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 PAX3 |
| Q39389208 | MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms |
| Q54333498 | MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. |
| Q35955250 | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. |
| Q39507329 | MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha |
| Q39028337 | MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells |
| Q38813671 | MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12. |
| Q34934907 | MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. |
| Q21245768 | MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma |
| Q31152555 | MiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395. |
| Q37688181 | MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs |
| Q57491234 | Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma |
| Q34538870 | MicroRNA Methylation in Colorectal Cancer |
| Q34725426 | MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma |
| Q33520915 | MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression |
| Q39238064 | MicroRNA expression profiles of LO2 cells expressing the wild-type and mutant HBx gene |
| Q37361575 | MicroRNA involvement in hepatocellular carcinoma |
| Q38479978 | MicroRNA mediates DNA methylation of target genes |
| Q37286627 | MicroRNA reexpression as differentiation therapy in cancer |
| Q34147480 | MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma |
| Q36278121 | MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. |
| Q38792595 | MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer |
| Q34426695 | MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31. |
| Q35614884 | MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells |
| Q38697537 | MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway. |
| Q54293083 | MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. |
| Q48513587 | MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib. |
| Q35906143 | MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. |
| Q86078239 | MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5) |
| Q38861368 | MicroRNA-1 properties in cancer regulatory networks and tumor biology |
| Q48505341 | MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7. |
| Q24655048 | MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib |
| Q34964774 | MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma |
| Q24628888 | MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index |
| Q53427004 | MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. |
| Q39428859 | MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer |
| Q34309924 | MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism |
| Q39576930 | MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia |
| Q39207834 | MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer |
| Q36085831 | MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma |
| Q39379374 | MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. |
| Q39439193 | MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). |
| Q92489548 | MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer |
| Q38945186 | MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer |
| Q37495218 | MicroRNA-based screens for synthetic lethal interactions with c-Myc |
| Q38390648 | MicroRNAs Contribute to Hepatocellular Carcinoma |
| Q26773183 | MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations |
| Q47839906 | MicroRNAs and Epigenetics |
| Q45944835 | MicroRNAs and complex diseases: from experimental results to computational models. |
| Q37852129 | MicroRNAs and epigenetics |
| Q38132116 | MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled |
| Q38201510 | MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans |
| Q34284404 | MicroRNAs associated with HBV infection and HBV-related HCC. |
| Q53077050 | MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. |
| Q37899669 | MicroRNAs in development and disease |
| Q38209676 | MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target |
| Q55444653 | MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. |
| Q34675280 | MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. |
| Q35552809 | MicroRNAs in mutagenesis, genomic instability, and DNA repair |
| Q37289662 | MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia |
| Q35388050 | MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals |
| Q37785997 | MicroRNAs, epigenetics and disease |
| Q24618771 | MicroRNAs: control and loss of control in human physiology and disease |
| Q33786949 | MicroRNAs: critical mediators of differentiation, development and disease |
| Q37339409 | MicroRNAs: key modulators of posttranscriptional gene expression. |
| Q36012679 | Mitochondrial regulation of epigenetics and its role in human diseases |
| Q38299569 | Modulation of Notch signaling as a therapeutic approach for liver cancer |
| Q36590130 | Modulation of cancer traits by tumor suppressor microRNAs |
| Q45367082 | Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. |
| Q34469322 | Modulation of the osteosarcoma expression phenotype by microRNAs |
| Q98200962 | Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis |
| Q35048768 | Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? |
| Q28383646 | Molecular classification and novel targets in hepatocellular carcinoma: recent advancements |
| Q89499519 | Molecular mechanism and inhibitory targets of dioscin in HepG2 cells |
| Q90903420 | Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma |
| Q53135369 | Mouse bone marrow stromal cells differentiate to neuron-like cells upon inhibition of BMP signaling. |
| Q38174389 | Myocardin and smooth muscle differentiation |
| Q37031728 | New insights on the role of epigenetic alterations in hepatocellular carcinoma |
| Q37630184 | New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma |
| Q91214802 | Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins |
| Q37994493 | Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets |
| Q47215507 | Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications |
| Q49645729 | Non-coding RNAs, epigenetics, and cancer: tying it all together. |
| Q35592207 | Noncoding RNA as therapeutic targets for hepatocellular carcinoma. |
| Q39387962 | Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer |
| Q37812094 | Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers |
| Q37033992 | Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype |
| Q37453166 | Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway |
| Q92992256 | PRMTs and miRNAs: functional cooperation in cancer and beyond |
| Q33675855 | PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. |
| Q92220024 | Photoradiosynthesis of 68Ga-Labeled HBED-CC-Azepin-MetMAb for Immuno-PET of c-MET Receptors |
| Q40305547 | Physcion induces apoptosis in hepatocellular carcinoma by modulating miR-370. |
| Q38070490 | Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer |
| Q38067621 | Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies |
| Q34102579 | Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis |
| Q51541233 | Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. |
| Q33275146 | Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma |
| Q30989557 | Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. |
| Q98287691 | Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy |
| Q28077331 | Regulation of class IIa HDAC activities: it is not only matter of subcellular localization |
| Q34803043 | Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs |
| Q38153384 | Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs |
| Q39030944 | Regulation of microRNA-1 (miR-1) expression in human cancer |
| Q37418150 | Regulation of microRNAs by epigenetics and their interplay involved in cancer |
| Q38746401 | Regulation of the MET oncogene: molecular mechanisms |
| Q38885469 | Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer |
| Q84106401 | Repression of transposable-elements - a microRNA anti-cancer defense mechanism? |
| Q39561328 | Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines |
| Q34389406 | Retracted: The Effect of miR-338-3p on HBx Deletion-Mutant (HBx-d382) Mediated Liver-Cell Proliferation through CyclinD1 Regulation |
| Q92705196 | Reversible photo-cross-linking of the GCN4 peptide containing 3-cyanovinylcarbazole amino acid to double-stranded DNA |
| Q27023524 | Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma |
| Q52743958 | Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database. |
| Q38264776 | Role of miRNA in head and neck squamous cell carcinoma |
| Q33737275 | Role of microRNA-1 in human cancer and its therapeutic potentials |
| Q24657152 | Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice |
| Q38190418 | Role of microRNAs in malignant mesothelioma. |
| Q42555454 | Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors |
| Q37376378 | Roles of microRNAs in the hepatitis B virus infection and related diseases |
| Q26795757 | Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease |
| Q33924619 | SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation |
| Q38441349 | Screening for genes, transcription factors and miRNAs associated with the myogenic and osteogenic differentiation of human adipose tissue-derived stem cells |
| Q34151439 | Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma |
| Q54439228 | Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. |
| Q44500035 | Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma |
| Q35070602 | Shielding the messenger (RNA): microRNA-based anticancer therapies |
| Q39319151 | Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer |
| Q37753238 | Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis |
| Q38777547 | Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs |
| Q36629543 | Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies |
| Q33793560 | Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution |
| Q33754007 | TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. |
| Q42182089 | Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells |
| Q51650211 | Targeting Apoptosis Through Foxp1, and N-cadherin with Glatiramer Acetate in Chick Embryos During Neural Tube Development. |
| Q34205088 | Targeting Notch signaling pathway to overcome drug resistance for cancer therapy |
| Q38744551 | Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol |
| Q37296159 | Targeting histone deacetylases for the treatment of disease |
| Q36021066 | Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression |
| Q57001209 | The Emerging Role of MicroRNAs in Hepatocellular Carcinoma |
| Q49562931 | The Importance of miRNAs and Epigenetics in Acute Lymphoblastic Leukemia Prognosis. |
| Q97561930 | The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways |
| Q38723285 | The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia |
| Q91469110 | The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis |
| Q24629522 | The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders |
| Q38109410 | The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases |
| Q38054883 | The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma |
| Q39508843 | The functional significance of miR-1 and miR-133a in renal cell carcinoma |
| Q27003050 | The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update |
| Q37286651 | The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation |
| Q27014062 | The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis |
| Q40928109 | The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer |
| Q39877545 | The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. |
| Q38056415 | The role and clinical implications of microRNAs in hepatocellular carcinoma |
| Q55387493 | The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer. |
| Q38213933 | The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q26861699 | The role of microRNAs in human liver cancers |
| Q37974141 | The role of microRNAs in liver cancer |
| Q34543731 | The role of microRNAs in liver cancer progression. |
| Q38210729 | The role of vitamins and minerals in modulating the expression of microRNA. |
| Q34163386 | The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer |
| Q38054873 | Therapeutically targeting microRNAs in liver cancer |
| Q37799251 | Towards novel paradigms for cancer therapy. |
| Q36966903 | Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. |
| Q36766784 | Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer |
| Q43147470 | Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma. |
| Q34318106 | Transcriptional and epigenetic regulation of human microRNAs |
| Q38139824 | Transcriptional and epigenetic regulation of neural crest induction during neurulation |
| Q39426763 | Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer |
| Q34251059 | Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma |
| Q41091875 | Tumor suppressor miR-1 inhibits tumor growth and metastasis by simultaneously targeting multiple genes |
| Q37982793 | Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells |
| Q36889632 | Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. |
| Q91810080 | Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer |
| Q28389159 | Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? |
| Q64271788 | Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT |
| Q38913245 | Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma |
| Q94597594 | Upregulation of microRNA‑1 inhibits proliferation and metastasis of breast cancer |
| Q45426468 | Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer |
| Q52369050 | circ-SHKBP1 Regulates the Angiogenesis of U87 Glioma-Exposed Endothelial Cells through miR-544a/FOXP1 and miR-379/FOXP2 Pathways. |
| Q33802900 | miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer |
| Q35640157 | miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma |
| Q28397782 | miR-1 induces growth arrest and apoptosis in malignant mesothelioma |
| Q38795917 | miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma |
| Q53694593 | miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT. |
| Q64063248 | miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9 |
| Q100395970 | miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR |
| Q35008738 | miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma |
| Q28579456 | miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival |
| Q34125608 | miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27(Kip1)- and MEK/ERK-mediated cell cycle regulation |
| Q39143346 | miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling |
| Q39125538 | miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. |
| Q92020429 | miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells |
| Q39472687 | miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line |
| Q37394073 | miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. |
| Q33954625 | microRNA and cancer |
| Q37873513 | microRNA involvement in hepatocellular carcinoma |
| Q34252329 | microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers |
| Q35840197 | microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. |
| Q53181847 | microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. |
| Q38224238 | microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer |
| Q49254805 | microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma. |
| Q38175875 | microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma |
| Q35011762 | microRNA: emerging therapeutic targets in acute ischemic diseases |
| Q90400723 | microRNAs: Key players in virus-associated hepatocellular carcinoma |
Search more.